![[SIGN thistle header]](../../../../images/page-header-template.jpg)
|
|
Guideline
topic: Pharmacological management of asthma |
||||||||
| Author |
Year |
Study type |
Quality rating |
Population |
Outomes measured |
Effect size |
Confidence intervals / p values |
Comments |
|
| Macaluso1 |
1986 |
RCT |
+ |
Asthma patients on theophylline |
FEV1, GC, cough, dyspnoea |
NS difference |
|||
| Mallfi & Turry |
1986 |
RCT |
+ |
? Asthma patients on other drugs? |
FEV1, VC global score |
??FEV1, VC global score |
P<0.001 |
||
| Philip-Joet2 |
1990 |
RCT |
+ |
? asthma patients on other drugs |
FEV, VC, PEFR, dyspnoea |
NS difference |
|||
| Rebuck3 |
1983 |
RCT |
+ |
17 patients on ICS, of 22 who were on theophylline |
FEV, VC, PEFR |
Slight AVC FEV1 |
P<0.05 |
||
| Salorinne4 |
1988 |
RCT |
+ |
Asthma patients on ISST theophylline |
FEV1, PEFR, symptoms suffered |
PEFR 10-20 l/min |
P<0.01 |
||
| Wolstenholme5 |
1989 |
RCT |
+ |
Asthma patients on DCSG + ICS |
FEV1, PEFR, symptomatic |
NS difference |
|||